Takeda will be investing approximately $30 billion into its U.S. operations over the next five years, the company announced.

Gilead Sciences is investing an additional $11 billion into its U.S. operations, the company announced this week, bringing ...

Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 celllines to develop and manufacture AAV ...

ACG Packaging Materials’ greenhouse gas emission reduction targets have been validated by the Science Based Targets ...

Schreiner MediPharm’s new Digital Display Label allows trial sponsors to eliminate time-consuming manual relabeling.